By modulating both NF-κB and PI3K/AKT pathways (Pan T. et al., 2022), lncRNA-NEAT1 amplifies inflammatory responses, promotes immune cell activation, and impairs cellular function, highlighting its potential as a diagnostic and therapeutic target in sepsis. The gene discussed is AKT1; the disease is Sepsis.